“It’s simply unacceptable to continue to allow cancer-causing chemicals to be used for things like glue, dry cleaning or stain removers when safer alternatives exist,” said Michal Freedhoff, assistant ...
BCRF awards $2.6M in grants to Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium researchers. Here’s what they’re investigating.
In this first-person essay, author and writing coach Emily Rubin shares her shock and resolve regarding a second breast cancer diagnosis after many years in remission.
In new research on the status of cancer disparities in the United States, American Cancer Society (ACS) scientists report higher cancer mortality rates among adults living in rural areas, certain ...
Science News Approval of First ‘Epigenetic’ Drug for a Solid Tumor Is Milestone The approval will not only benefit current patients, but will also spur more research into the biology of other rare ...
Collins, who played center for six team during his 13-year NBA career, is no stranger to breaking barriers and overcoming challenges in the public arena. In 2013, at age 34, he came out in a Sports ...
“Amazing Race” winners Catherine Wreford Ledlow and Craig Ramsay inspire resiliency when facing cancer.
“The data we reviewed showed that patients who received follow-up transplants or tumor removal after immunotherapy reduced the size of their tumors lived much longer than patients who just remained on ...
“Liquid biopsies” make headlines for their potential to detect multiple cancers in their earliest stages, but it’s too soon to tell whether the tests are accurate and safe enough for widespread use, ...
From 2010 to 2020, breast cancer deaths among women ages 20 to 49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according ...
“These updated recommendations will help to improve compliance with screening and reduce the risk of cervical cancer,” said Dr. Robert Smith, senior vice president, early cancer detection science at ...
All 49 rectal cancer patients treated with Jemperli for six months had a clinical complete response and avoided surgery. In the second cohort, 35 of the 54 (65%) had a complete response, and 33 opted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results